TikoMed will be sending team to BIO International in Boston
Jun, 4-7, mon,tue,wed,thu
The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships.
TikoMed will be sending representatives to take the opportunity to network and progress partner discussions for its projects. Dicussions will be focused on outlicensing of ILB, TikoMed’s neurology project but also partnering initiatives for IBsolvMIR a pharmacological product in Phase 2 intended to improve outcome for celltharapies.